Prognostic markers in human breast cancer

Details Prognostic markers in human breast cancer Prognostic markers in human breast cancer

1993-10-20

1995-05-16

Scheiner, Toni R.

Chemistry: molecular biology and microbiology

Measuring or testing process involving enzymes or...

Involving antigen-antibody binding, specific binding protein...

435 79, 435 792, 435 794, 436 63, 436 64, 436813, 424 149, G01N 33574, G01N 3353, G01N 33543

Patent

active

054159962

ABSTRACT:
Methods and compositions are provided for determining the prognosis of human breast carcinoma through in vitro or in vivo detection of an antigen expressed and shed by cancer cells. The presence of this antigen is positively correlated with the presence of cancer and the number of cells expressing this antigen is correlated with a high incidence of tumor relapse, distant relapse and shortened relapse-free survival time.

REFERENCES:
patent: 5019497 (1991-05-01), Olsson
Martensson, S., et al., Cancer Res, vol. 48(8), pp. 2125-2131, Apr. 15, 1988.

Affiliated with

Also associated with

Rating

Prognostic markers in human breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prognostic markers in human breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prognostic markers in human breast cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-637162